Crovalimab (Anti-Complement C5)Crovalimab (Anti-Complement C5)
Move your mouse over image or click to enlarge

Crovalimab (Anti-Complement C5)

Crovalimab (Anti-Complement C5) is a humanized recycling monoclonal antibody directed against the complement pathway protein C5, with potential complement pathway inhibitory and immunomodulating activities. MW : 145.28 KD.
Cat# Size Price Qty Buy
A2812-1mg*25 1mg*25
£4,152.00
A2812-1mg*5 1mg*5
£1,384.00
A2812-1mg 1mg
£441.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2812

Related Documents